TUPPER COLLEEN (EVP & Chief Financial Officer) received a stock award from COLLEGIUM PHARMACEUTICAL, INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 2 awards
Filed: 2/12/2026ACC: 0001862082-26-000002
Officer· EVP & Chief Financial Officer
Since May 2021
+20.61K
Net shares
Net buyer
$1.80M
Total sold
0
Open market trades
0B · 0S
4
Total transactions
59.16K acquired · 38.54K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
+26.42K
Price / share
—
Trade value
—
% of position
20.9%
2/10/2026
126.67K→153.09K
Common Stock
Direct
Shares
+32.73K
Price / share
—
Trade value
—
% of position
21.4%
2/10/2026
153.09K→185.82K
Common Stock
Direct
Shares
−11.86K
Price / share
$46.75
Trade value
$554.50K
% of position
6.4%
2/10/2026
185.82K→173.96K
Common Stock
Direct
Shares
−26.68K
Price / share
$46.75
Trade value
$1.25M
% of position
15.3%
2/10/2026
173.96K→147.28K
Total
Net shares
+20.61K
Net value
-$1.80M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/10/2026 | A · Award | +26.42K | — | — | 20.9% | 126.67K | 153.09K |
| Common Stock Direct | 2/10/2026 | A · Award | +32.73K | — | — | 21.4% | 153.09K | 185.82K |
| Common Stock Direct | 2/10/2026 | F · Tax Withholding | −11.86K | $46.75 | $554.50K | 6.4% | 185.82K | 173.96K |
| Common Stock Direct | 2/10/2026 | F · Tax Withholding | −26.68K | $46.75 | $1.25M | 15.3% | 173.96K | 147.28K |
| Total | +20.61K | -$1.80M | ||||||
Derivative Transactions0
No derivative transactions reported